Oramed Pharmaceuticals, Inc. (ORMP)
3.48
+0.05
(+1.46%)
USD |
NASDAQ |
Feb 10, 12:49
Oramed Pharmaceuticals Total Assets (Quarterly) : 220.49M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lifeward Ltd. | 23.17M |
| Bristol Myers Squibb Co. | -- |
| Instil Bio, Inc. | 211.77M |
| Nektar Therapeutics | 301.35M |
| Innoviva, Inc. | 1.429B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.16M |
| Shareholders Equity (Quarterly) | 203.28M |
| Debt to Equity Ratio | 0.0042 |
| Current Ratio | 22.24 |
| Net Debt Paydown Yield | -0.07% |